Mirae Asset Global ETFs Holdings’s Phathom Pharmaceuticals PHAT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$241K	Buy	21,732 +3,272	+18%	+$41.3K	﹤0.01%	2255
2025 Q4	$306K	Sell	18,460 -942	-5%	-$13.5K	﹤0.01%	2143
2025 Q3	$228K	Sell	19,402 -3,932	-17%	-$40.6K	﹤0.01%	2257
2025 Q2	$224K	Buy	23,334 +171	+0.7%	+$946	﹤0.01%	2221
2025 Q1	$145K	Buy	23,163 +1,014	+5%	+$6.16K	﹤0.01%	2471
2024 Q4	$180K	Buy	22,149 +3,408	+18%	+$42.2K	﹤0.01%	2441
2024 Q3	$339K	Buy	18,741 +2,471	+15%	+$34.5K	﹤0.01%	2106
2024 Q2	$168K	Buy	+16,270	New	+$168K	﹤0.01%	2345

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PHAT Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Phathom Pharmaceuticals (PHAT) stake by 18% in Q1 2026, buying an estimated $41.3K and bringing the position to 21,732 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Mirae Asset Global ETFs Holdings first reported a position in PHAT in Q2 2024 and has held it in 8 quarters since. The position peaked at $339K in Q3 2024. 174 funds tracked by Wall St. Rank hold PHAT as of Q1 2026.

Mirae Asset Global ETFs Holdings held 21,732 shares of Phathom Pharmaceuticals worth $241K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 3,272 Phathom Pharmaceuticals shares in Q1 2026, an estimated $41.3K.
Phathom Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2255 holding.
Mirae Asset Global ETFs Holdings first reported a position in Phathom Pharmaceuticals in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Phathom Pharmaceuticals position peaked at $339K in Q3 2024.
174 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.